Phase 1 / 2 Trial of Idasanutlin in Combination With Ixazomib and Dexamethasone in Patients With 17p Deleted, Relapsed Multiple Myeloma
Phase of Trial: Phase I/II
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Idasanutlin (Primary) ; Ixazomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 09 Jan 2018 Status changed from suspended to recruiting.
- 07 Dec 2017 Status changed from recruiting to suspended as per study design.
- 10 Jun 2017 Biomarkers information updated